Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Frances Arnold

At a glance: Frances Arnold is Director at Generate Biomedicines (GENB). Their latest SEC Form 4, filed Nov 4, 2026, reported a sale of $185K. On file: 0 purchase lines ($0) and 15 sale lines ($617K).

Disclosed holdings: about $2.3M of GENB stock: 220,063 shares reported on their latest Form 4 (filed Nov 4, 2026), valued at the Nov 19, 2026 close of $10.38. This counts only GENB shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

Director at Generate Biomedicines, Inc. (GENB); Director at Alphabet Inc. (GOOG)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $617K

Frances Arnold's InsiderPrint

15 trades from SEC Form 4 filings, 2025 to 2026, drawn as one fingerprint.

InsiderPrint of Frances Arnold: 15 trades, 2025 to 20262025: 0 buys, 3 sales2026: 0 buys, 12 sales

Reading this print: Almost only sells, trading about 15 times a year, typically $32K a trade; most sales are on a pre-planned 10b5-1 schedule.

  • Bump outward: a purchase (0)
  • Dent inward: a sale (15)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Insiders with a similar print

  1. Leonard E. PostDirector · CGON · 98% match
  2. Emily RollinsDirector · DLB · 97% match
  3. James A. BeerDirector · DOCU · 97% match
  4. Daniel J. HennessyCEO, Chair · HCIC · 97% match
  5. Anna MarrsGroup Pres., Gmns · AXP · 96% match

Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.

Reported trades

Filed Stock Type Shares Price Value Since
Nov 4SEC GENBGenerate Biomedicines, Inc. Sell Plan 11,409220,063 held (−5%) $16.19 $185K -35.9%
Oct 30SEC GOOGAlphabet Inc. Sell Plan 8219,157 held (−0%) $284.00 $23K -2.9%
Oct 2SEC GOOGAlphabet Inc. Sell Plan 8319,076 held (−0%) $340.45 $28K -19.0%
Sep 3SEC GENBGenerate Biomedicines, Inc. Sell Plan 1,000231,472 held (−0%) $16.00 $16K -35.1%
Aug 31SEC GOOGAlphabet Inc. Sell Plan 8218,995 held (−0%) $337.71 $28K -18.3%
Jul 30SEC GOOGAlphabet Inc. Sell Plan 8218,914 held (−0%) $333.39 $27K -17.3%
Jun 30SEC GOOGAlphabet Inc. Sell Plan 11218,833 held (−1%) $351.28 $39K -21.5%
Jun 1SEC GOOGAlphabet Inc. Sell Plan 10218,721 held (−1%) $381.00 $39K -27.6%
May 1SEC GOOGAlphabet Inc. Sell Plan 10218,621 held (−1%) $371.00 $38K -25.6%
Mar 31SEC GOOGAlphabet Inc. Sell Plan 10218,316 held (−1%) $275.19 $28K +0.3%
Mar 4SEC GOOGAlphabet Inc. Sell Plan 11218,418 held (−1%) $302.99 $34K -8.9%
Jan 30SEC GOOGAlphabet Inc. Sell Plan 10218,307 held (−1%) $340.00 $35K -18.9%
Dec 31SEC GOOGAlphabet Inc. Sell Plan 10218,205 held (−1%) $313.45 $32K -12.0%
Dec 2SEC GOOGAlphabet Inc. Sell Plan 10218,104 held (−1%) $317.66 $32K -13.2%
Nov 3SEC GOOGAlphabet Inc. Sell Plan 11218,004 held (−1%) $291.80 $33K -5.5%
  • Sell

    Director Frances Arnold sold $185K of GENB at $16.19 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Frances Arnold sold $23K of GOOG at $284.00 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Frances Arnold sold $28K of GOOG at $340.45 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Frances Arnold sold $16K of GENB at $16.00 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Frances Arnold sold $28K of GOOG at $337.71 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Frances Arnold sold $27K of GOOG at $333.39 — pre-scheduled 10b5-1 plan sale.

Follow Frances Arnold

Get one email when Frances Arnold files a new purchase or sale. Free.

At most one email a day about Frances Arnold, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.